In animal models, the new compound modulated a key enzyme, reducing or eliminating production of problematic protein fragments; human clinical trials needed
Colorectal cancer is now a leading cause of cancer death among people under 50, with rates of new diagnoses rising. Young mother and cancer survivor Teri Rivera was told she was too young to have colon cancer and is glad she listened to her body after finally getting screened, only…
Further studies may reveal different patterns, including the possibility that evidence of abuse may not be apparent for months to follow, or failure by clinicians to identify abuse.
A UCI Health-led study of trauma care in Southern California during the early months of the COVID-19 pandemic and “stay-at-home” period shows an increase in penetrating injuries such as gunshot wounds and a decrease in blunt trauma, usually associated with vehicle collisions and pedestrian injuries. The multi-center analysis reviewed nearly…
In the new book he co-wrote, Salzman reveals the hidden rules that govern who owns what — from the reclining space behind airline seats to HBO passwords.
A repurposed drug used to treat arthritis did not significantly improve the outcomes of patients with severe COVID-19 pneumonia. Tocilizumab did not significantly improve clinical status or mortality rate at 28 days for participants who received it compared to a placebo.
A UC Davis Health team today announced the launch of the world’s first FDA-approved human clinical trial to treat the most serious form of spina bifida. The trial involves the use of stem cells, applied during a surgery before birth.
New studies show that many people see friends and family – and even pleasant strangers – as less of a COVID-19 risk, which partly explains why some people drop their guard with family and at social gatherings.
Health Media Contacts
Find the best contact for health-related media inquiries.
